Obara I - Search Results

1

Histamine in diabetes: Is it time to reconsider?

Pini A, Obara I, Battell E, Chazot PL, Rosa AC. Pini A, et al. Among authors: obara i. Pharmacol Res. 2016 Sep;111:316-324. doi: 10.1016/j.phrs.2016.06.021. Epub 2016 Jun 22. Pharmacol Res. 2016. PMID: 27343700 Free article. Review.

2

CNS-Sparing Histamine H₃ Receptor Antagonist as a Candidate to Prevent the Diabetes-Associated Gastrointestinal Symptoms.

Rosa AC, Nardini P, Sgambellone S, Gurrieri M, Spampinato SF, Dell'Accio A, Chazot PL, Obara I, Liu WL, Pini A. Rosa AC, et al. Among authors: obara i. Biomolecules. 2022 Jan 22;12(2):184. doi: 10.3390/biom12020184. Biomolecules. 2022. PMID: 35204685 Free PMC article.

3

Histamine, histamine receptors, and neuropathic pain relief.

Obara I, Telezhkin V, Alrashdi I, Chazot PL. Obara I, et al. Br J Pharmacol. 2020 Feb;177(3):580-599. doi: 10.1111/bph.14696. Epub 2019 Jun 7. Br J Pharmacol. 2020. PMID: 31046146 Free PMC article. Review.

4

Votucalis, a Novel Centrally Sparing Histamine-Binding Protein, Attenuates Histaminergic Itch and Neuropathic Pain in Mice.

Alrashdi I, Alsubaiyel A, Chan M, Battell EE, Ennaceur A, Nunn MA, Weston-Davies W, Chazot PL, Obara I. Alrashdi I, et al. Among authors: obara i. Front Pharmacol. 2022 Mar 8;13:846683. doi: 10.3389/fphar.2022.846683. eCollection 2022. Front Pharmacol. 2022. PMID: 35350753 Free PMC article.

5

Histamine research advancements in the second year of the COVID-19 pandemic: report of the European Histamine Research Society (EHRS).

Obara I, Fernandes JPS, Tiligada E. Obara I, et al. Inflamm Res. 2022 Aug;71(7-8):995-998. doi: 10.1007/s00011-022-01589-9. Epub 2022 Jun 1. Inflamm Res. 2022. PMID: 35648157 Free PMC article.

6

Inhibition of the mammalian target of rapamycin complex 1 signaling pathway reduces itch behaviour in mice.

Obara I, Medrano MC, Signoret-Genest J, Jiménez-Díaz L, Géranton SM, Hunt SP. Obara I, et al. Pain. 2015 Aug;156(8):1519-1529. doi: 10.1097/j.pain.0000000000000197. Pain. 2015. PMID: 25906350

7

Local peripheral antinociceptive effects of 14-O-methyloxymorphone derivatives in inflammatory and neuropathic pain in the rat.

Obara I, Makuch W, Spetea M, Schütz J, Schmidhammer H, Przewlocki R, Przewlocka B. Obara I, et al. Eur J Pharmacol. 2007 Mar 8;558(1-3):60-7. doi: 10.1016/j.ejphar.2006.11.037. Epub 2006 Nov 25. Eur J Pharmacol. 2007. PMID: 17204264

8

Nerve injury-induced changes in Homer/glutamate receptor signaling contribute to the development and maintenance of neuropathic pain.

Obara I, Goulding SP, Hu JH, Klugmann M, Worley PF, Szumlinski KK. Obara I, et al. Pain. 2013 Oct;154(10):1932-1945. doi: 10.1016/j.pain.2013.03.035. Epub 2013 Apr 2. Pain. 2013. PMID: 23685007 Free PMC article.

9

A review and narrative synthesis of community pharmacist-led interventions to tackle medicines for pain that are misused.

Mills VG, Meaadi J, Nazar H, Obara I. Mills VG, et al. Among authors: obara i. Int J Pharm Pract. 2022 Aug 9;30(4):305-314. doi: 10.1093/ijpp/riac041. Int J Pharm Pract. 2022. PMID: 35639757 Review.

10

Meeting report of the 49th annual meeting of the European Histamine Research Society (EHRS).

Kay L, Obara I. Kay L, et al. Among authors: obara i. Inflamm Res. 2020 Oct;69(10):1015-1017. doi: 10.1007/s00011-020-01390-6. Epub 2020 Aug 11. Inflamm Res. 2020. PMID: 32780184 Free PMC article.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

73 results

Search Page

Filters